Dr. Connie Lehman, founder of Clairity, reveals how her FDA-authorized breakthrough AI technology transforms routine mammograms into powerful tools for predicting future cancer risk. She discusses the science behind the innovation, the journey from lab to clinic, and Clairity’s potential to save lives, lower costs, and keep our country at the forefront of medical breakthroughs.

From Medicaid reforms to trade policy and biotech’s future, we recap key themes from recent episodes. Even during August recess, DC is still buzzing as we spotlight the issues to watch when lawmakers return this fall.

In this episode of the D.C. Download, we’re joined by Practice Group Chair and former U.S. International Trade Commissioner Deanna Okun for a deep dive into everything you need to know about tariffs and trade deals. 

In this episode of D.C. Download, we sit down with Keith Murphy, CEO of VivoSim, to explore New Approach Methodologies (NAMs) — cutting-edge, human-focused techniques revolutionizing drug testing and disease research. From bioprinted tissues to advanced simulations, Keith sheds light on the future of biotech innovation.

In this episode of D.C. Download, the Public Policy team welcomes Jennifer Evans, Managing Partner of Polsinelli’s Denver office, seasoned health care attorney, and former deputy Medicaid director for the state of Colorado. Drawing on her deep experience in both state and federal policy, Jennifer breaks down the Medicaid provisions in the recent reconciliation bill—dubbed the “Big Beautiful Bill.” She explains how changes to state financing, provider payments, and new eligibility requirements—like work mandates and more frequent re-enrollment—could impact hospitals, health systems, and patients across the country.

Welcome to the first episode of D.C. Download, featuring Polsinelli public policy advisors, Harry Sporidis and Marisa Campbell, who will be diving into timely topics from Capitol Hill.

In this inaugural episode, we dig into the details of The Big Beautiful Bill - what has transpired in the last few weeks and what may be on the horizon.